Twin Focus Capital Partners, LLC Pacira Bio Sciences, Inc. Transaction History

Twin Focus Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$41.31 - $52.16 $186,555 - $235,554	-4,516 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$32.85 - $52.0 $148,350 - $234,832	4,516 New	4,516 $222,000
Q1 2018 May 11, 2018	SELL	$29.98 - $46.35 $135,389 - $209,316	-4,516 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $143,834 - $212,026	4,516	4,516 $206,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Twin Focus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Twin Focus Capital Partners, LLC with notifications on news.